Amarin Corp Plc (AMRN)

[hamkypamky]

I'm not defending management in any way but having prepared similar Q&A packs for a biotech investor day. My advice:

1. Confrontational or aggressive questions are pointless. The company will refuse to entertain them.

That rules out 7 & 18. The company is NOT going to say reps are doing a poor job publicly. And even if layoffs are coming down the line they will never make an announcement via a q&a (maybe in the conference proper).

2. M&A and litigation questions are equally pointless. Litigation = no comment and even if M&A is asked it will be answered with boilerplate meaningless drivel.

3. For what it's worth my vote is for 1, 2 and 15.